Theriva Historical Income Statement
| TOVX Stock | USD 1.34 0.06 4.69% |
Historical analysis of Theriva Biologics income statement accounts such as Total Operating Expenses of 13.9 M, Total Other Income Expense Net of 1.5 M, Research Development of 9.5 M or Interest Expense of 519.2 K can show how well Theriva Biologics performed in making a profits. Evaluating Theriva Biologics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Theriva Biologics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Theriva Biologics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Theriva Biologics is a good buy for the upcoming year.
Theriva |
About Theriva Income Statement Analysis
Theriva Biologics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Theriva Biologics shareholders. The income statement also shows Theriva investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Theriva Biologics Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Theriva Biologics. It is also known as Theriva Biologics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on Theriva Biologics income statement and represents the costs associated with goods and services Theriva Biologics provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Theriva Biologics minus its cost of goods sold. It is profit before Theriva Biologics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Most accounts from Theriva Biologics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Theriva Biologics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theriva Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For more information on how to buy Theriva Stock please use our How to Invest in Theriva Biologics guide.At this time, Theriva Biologics' Cost Of Revenue is fairly stable compared to the past year. Total Other Income Expense Net is likely to rise to about 1.5 M in 2024, whereas Depreciation And Amortization is likely to drop slightly above 101.5 K in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 14.3M | 21.6M | 21.4M | 13.9M | Cost Of Revenue | 87K | 268K | 135K | 183.7K |
Theriva Biologics income statement Correlations
Click cells to compare fundamentals
Theriva Biologics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Theriva Stock Analysis
When running Theriva Biologics' price analysis, check to measure Theriva Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theriva Biologics is operating at the current time. Most of Theriva Biologics' value examination focuses on studying past and present price action to predict the probability of Theriva Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theriva Biologics' price. Additionally, you may evaluate how the addition of Theriva Biologics to your portfolios can decrease your overall portfolio volatility.